Vertex Pharmaceuticals (VRTX)

Other Income/Expenses (Net)

$402.90M

TTM · Period ending: · USD

VRTX logo

VRTX Other Income/Expenses (Net)

Latest reported$402.90M
VRTX TTM Other Income/Expenses (Net) ($4.10M → $402.90M)
High-resolution chart · PNG

VRTX other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
402,900,000
389,900,000
375,400,000
455,300,000
450,500,000
442,100,000
481,400,000
530,000,000
563,300,000
574,900,000
547,800,000
432,000,000
340,600,000
123,600,000
-75,000,000
-125,123,000
-146,523,000
-70,923,000
-51,663,000
97,991,000
143,321,000
256,358,000
260,508,000
243,162,000
140,865,000
91,306,000
197,353,000
-23,357,000
-63,828,000
-77,293,000
-34,909,000
47,021,000
25,032,000
-35,882,000
-138,932,000
-144,971,000
-74,151,000
-78,324,000
-77,302,000
-80,312,000
-82,465,000
-80,788,000
-90,921,000
-97,710,000
-99,624,000
-57,781,000
-46,281,000
-83,239,000
-54,209,000
-82,933,000
-72,665,000
-9,870,000
-18,567,000
-15,624,000
-14,713,000
-24,518,000
-35,574,000
-40,919,000
-53,375,000
-54,032,000
-48,304,000
-69,757,000
-58,549,000
-540,250,000
-532,213,000
-515,910,000
-511,700,000
-16,710,000
-14,794,000
-504,000
2,857,000
9,323,000
15,501,000
23,194,000
28,513,000
-149,442,000
-145,879,000
-152,168,000
-157,400,000
40,952,000
-6,469,000
-10,425,000
-15,414,000
-36,844,000
-2,930,000
-2,573,000
-4,143,000
-71,188,000
-69,176,000
-68,062,000
-62,767,000
-53,174,000
-49,605,000
-48,684,000
-50,089,000
-1,601,000
2,924,000
8,265,000
8,265,000
12,108,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.